Libraries of modified fibronectin type III tenth domain-containing polypeptides
Abstract:
The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.
Public/Granted literature
Information query
Patent Agency Ranking
0/0